187 related articles for article (PubMed ID: 23943387)
1. Trends and patterns of utilization in post-treatment surveillance imaging among patients treated for hepatocellular carcinoma.
Hyder O; Dodson RM; Weiss M; Cosgrove DP; Herman JM; Geschwind JH; Kamel IR; Pawlik TM
J Gastrointest Surg; 2013 Oct; 17(10):1774-1783. PubMed ID: 23943387
[TBL] [Abstract][Full Text] [Related]
2. Postoperative imaging surveillance for hepatocellular carcinoma: How much is enough?
Mirdad RS; Madison Hyer J; Diaz A; Tsilimigras DI; Azap RA; Paro A; Pawlik TM
J Surg Oncol; 2021 Jun; 123(7):1568-1577. PubMed ID: 33596330
[TBL] [Abstract][Full Text] [Related]
3. Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases.
Hyder O; Dodson RM; Mayo SC; Schneider EB; Weiss MJ; Herman JM; Wolfgang CL; Pawlik TM
Surgery; 2013 Aug; 154(2):256-65. PubMed ID: 23889953
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables.
Kornberg A; Küpper B; Tannapfel A; Katenkamp K; Thrum K; Habrecht O; Wilberg J
Eur J Surg Oncol; 2010 Mar; 36(3):275-80. PubMed ID: 19857941
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma.
Nicoli N; Casaril A; Marchiori L; Mangiante G; Marini G; Colombari R; Portuese A; Hasheminia AR
Chir Ital; 2000; 52(1):29-40. PubMed ID: 10832524
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis.
Miura JT; Johnston FM; Tsai S; Eastwood D; Banerjee A; Christians KK; Turaga KK; Gamblin TC
HPB (Oxford); 2015 Oct; 17(10):896-901. PubMed ID: 26228076
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis.
Karim MA; Singal AG; Kum HC; Lee YT; Park S; Rich NE; Noureddin M; Yang JD
Cancer Res Commun; 2023 May; 3(5):874-883. PubMed ID: 37377892
[TBL] [Abstract][Full Text] [Related]
8. Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival.
Lee DD; Sapisochin G; Mehta N; Gorgen A; Musto KR; Hajda H; Yao FY; Hodge DO; Carter RE; Harnois DM
Transplantation; 2020 Oct; 104(10):2105-2112. PubMed ID: 31972705
[TBL] [Abstract][Full Text] [Related]
9. Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients.
Gaba RC; Kallwitz ER; Parvinian A; Bui JT; Von Roenn NM; Berkes JL; Cotler SJ
Ann Hepatol; 2013; 12(5):766-73. PubMed ID: 24018494
[TBL] [Abstract][Full Text] [Related]
10. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.
Mironov O; Jaberi A; Kachura JR
J Vasc Interv Radiol; 2017 Mar; 28(3):325-333. PubMed ID: 28073607
[TBL] [Abstract][Full Text] [Related]
11. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.
Zhang X; El-Serag HB; Thrift AP
Cancer Causes Control; 2021 Apr; 32(4):317-325. PubMed ID: 33394207
[TBL] [Abstract][Full Text] [Related]
12. Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery?
Chirica M; Scatton O; Massault PP; Aloia T; Randone B; Dousset B; Legmann P; Soubrane O
Arch Surg; 2008 Jun; 143(6):538-43; discussion 543. PubMed ID: 18559745
[TBL] [Abstract][Full Text] [Related]
13. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
14. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
[TBL] [Abstract][Full Text] [Related]
15. Comparative assessment of the safety and effectiveness of radiofrequency ablation among elderly medicare beneficiaries with hepatocellular carcinoma.
Massarweh NN; Park JO; Yeung RS; Flum DR
Ann Surg Oncol; 2012 Apr; 19(4):1058-65. PubMed ID: 21947695
[TBL] [Abstract][Full Text] [Related]
16. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
17. Management of the single liver nodule in a cirrhotic patient: a decision analysis model.
El-Serag HB; Mallat DB; Rabeneck L
J Clin Gastroenterol; 2005 Feb; 39(2):152-9. PubMed ID: 15681913
[TBL] [Abstract][Full Text] [Related]
18. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
[TBL] [Abstract][Full Text] [Related]
19. Predictors of survival after resection of early hepatocellular carcinoma.
Nathan H; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
[TBL] [Abstract][Full Text] [Related]
20. Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation.
Liu W; Zheng Y; Zou R; Shen J; He W; Yang Z; Zhang Y; Li B; Yuan Y
BMC Cancer; 2018 Nov; 18(1):1186. PubMed ID: 30497418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
